Search

Dale R. Miller

Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1673, 1693
Total Applications
838
Issued Applications
502
Pending Applications
84
Abandoned Applications
276

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11469726 [patent_doc_number] => 20170056509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'HYALURONIC ACID MODIFIED BY SPHINGOSINE-1-PHOSPHORIC ACID' [patent_app_type] => utility [patent_app_number] => 15/123359 [patent_app_country] => US [patent_app_date] => 2015-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4754 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15123359 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/123359
Hyaluronic acid modified by sphingosine-1-phosphoric acid Mar 4, 2015 Issued
Array ( [id] => 11290513 [patent_doc_number] => 20160340445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'ORALLY AVAILABLE COMPOUNDS, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS ANTI-ADHESIVE DRUGS FOR TREATING E. COLI INDUCED INFLAMMATORY BOWEL DISEASES SUCH AS CROHN\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 15/113986 [patent_app_country] => US [patent_app_date] => 2015-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 35720 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113986 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/113986
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating Jan 22, 2015 Issued
Array ( [id] => 14003255 [patent_doc_number] => 10220055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-05 [patent_title] => Composition effective against viral conjunctivitis [patent_app_type] => utility [patent_app_number] => 15/112778 [patent_app_country] => US [patent_app_date] => 2015-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6117 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15112778 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/112778
Composition effective against viral conjunctivitis Jan 19, 2015 Issued
Array ( [id] => 11311758 [patent_doc_number] => 20160347868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-01 [patent_title] => 'FUC3S4S SUBSTITUTED OLIGOGLYCOSAMINOGLYCAN AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 15/110664 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17418 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110664 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/110664
Fuc3S4S substituted oligoglycosaminoglycan and preparation method thereof Dec 18, 2014 Issued
Array ( [id] => 13300315 [patent_doc_number] => 20180201694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => CHITIN DERIVATIVES, METHOD FOR PRODUCTION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/105153 [patent_app_country] => US [patent_app_date] => 2014-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17553 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105153 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/105153
CHITIN DERIVATIVES, METHOD FOR PRODUCTION AND USES THEREOF Dec 15, 2014 Abandoned
Array ( [id] => 17451935 [patent_doc_number] => 11266772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-08 [patent_title] => Use of heparin and carbohydrates to treat cancer [patent_app_type] => utility [patent_app_number] => 14/565387 [patent_app_country] => US [patent_app_date] => 2014-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6157 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14565387 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/565387
Use of heparin and carbohydrates to treat cancer Dec 8, 2014 Issued
Array ( [id] => 14357791 [patent_doc_number] => 10300176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Catheter lock solution formulations [patent_app_type] => utility [patent_app_number] => 14/554018 [patent_app_country] => US [patent_app_date] => 2014-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 3423 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14554018 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/554018
Catheter lock solution formulations Nov 24, 2014 Issued
Array ( [id] => 11099573 [patent_doc_number] => 20160296544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'METHODS FOR PREVENTING OR MITIGATING ACUTE ALLERGIC RESPONSES USING HUMAN MILK OLIGOSACCHARIDES' [patent_app_type] => utility [patent_app_number] => 15/037743 [patent_app_country] => US [patent_app_date] => 2014-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5997 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037743 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/037743
Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides Nov 17, 2014 Issued
Array ( [id] => 11082197 [patent_doc_number] => 20160279162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'MICELLE-BASED DELIVERY OF DERMAL THERAPEUTIC MATERIALS' [patent_app_type] => utility [patent_app_number] => 15/037312 [patent_app_country] => US [patent_app_date] => 2014-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12527 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037312 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/037312
MICELLE-BASED DELIVERY OF DERMAL THERAPEUTIC MATERIALS Nov 17, 2014 Abandoned
Array ( [id] => 11031606 [patent_doc_number] => 20160228562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'MUTUAL PRODRUG COMPRISING SHORT CHAIN FATTY ACIDS AND ZEBULARINE OR 1\'-CYANO-CYTARABINE FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 15/029852 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9664 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029852 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/029852
Mutual prodrug comprising short chain fatty acids and zebularine or 1'-cyano-cytarabine for cancer treatment Nov 13, 2014 Issued
Array ( [id] => 11323784 [patent_doc_number] => 20160354395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'INFANT FORMULAS CONTAINING A 2-FUCOSYLATED OLIGOSACCHARIDE FOR TREATMENT OR PREVENTION OF INFLUENZA INFECTION' [patent_app_type] => utility [patent_app_number] => 15/036841 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9041 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036841 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/036841
INFANT FORMULAS CONTAINING A 2-FUCOSYLATED OLIGOSACCHARIDE FOR TREATMENT OR PREVENTION OF INFLUENZA INFECTION Nov 13, 2014 Abandoned
Array ( [id] => 11075767 [patent_doc_number] => 20160272731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'Chitin Nanocrystals and Process for Preparation Thereof' [patent_app_type] => utility [patent_app_number] => 15/036080 [patent_app_country] => US [patent_app_date] => 2014-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8776 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036080 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/036080
Chitin nanocrystals and process for preparation thereof Nov 11, 2014 Issued
Array ( [id] => 11083766 [patent_doc_number] => 20160280731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'CRYSTALLINE FORMS B, C, and D OF CANAGLIFLOZIN' [patent_app_type] => utility [patent_app_number] => 15/035751 [patent_app_country] => US [patent_app_date] => 2014-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5244 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035751 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/035751
CRYSTALLINE FORMS B, C, and D OF CANAGLIFLOZIN Nov 10, 2014 Abandoned
Array ( [id] => 9910250 [patent_doc_number] => 20150065452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'ANTI-FATIGUE COMPOSITION, FORMULATION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/535257 [patent_app_country] => US [patent_app_date] => 2014-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3239 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14535257 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/535257
Anti-fatigue composition, formulation and use thereof Nov 5, 2014 Issued
Array ( [id] => 14031259 [patent_doc_number] => 10227368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-12 [patent_title] => Generation of glucosamine from plant material [patent_app_type] => utility [patent_app_number] => 15/033736 [patent_app_country] => US [patent_app_date] => 2014-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4123 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033736 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/033736
Generation of glucosamine from plant material Nov 4, 2014 Issued
Array ( [id] => 11053283 [patent_doc_number] => 20160250245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'Methods and Pharmaceutical Composition for the Treatment of Polyomavirus Infections' [patent_app_type] => utility [patent_app_number] => 15/030416 [patent_app_country] => US [patent_app_date] => 2014-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6108 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030416 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/030416
Methods and Pharmaceutical Composition for the Treatment of Polyomavirus Infections Oct 19, 2014 Abandoned
Array ( [id] => 11060805 [patent_doc_number] => 20160257767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'Acylation Process' [patent_app_type] => utility [patent_app_number] => 15/029011 [patent_app_country] => US [patent_app_date] => 2014-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10903 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029011 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/029011
Acylation process Oct 14, 2014 Issued
Array ( [id] => 11060804 [patent_doc_number] => 20160257766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'Acylation Process' [patent_app_type] => utility [patent_app_number] => 15/029006 [patent_app_country] => US [patent_app_date] => 2014-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9297 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029006 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/029006
Acylation process Oct 14, 2014 Issued
Array ( [id] => 9858678 [patent_doc_number] => 20150038695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS AND EFFICIENT METHODS OF PREPARING THEM' [patent_app_type] => utility [patent_app_number] => 14/513855 [patent_app_country] => US [patent_app_date] => 2014-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12953 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14513855 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/513855
Regioselectively substituted cellulose esters and efficient methods of preparing them Oct 13, 2014 Issued
Array ( [id] => 11054510 [patent_doc_number] => 20160251470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'ZWITTERIONIC POLYSACCHARIDE POLYMERS HAVING ANTIFOULING, ANTIMICROBIAL AND OPTICAL TRANSPARENCY PROPERTIES' [patent_app_type] => utility [patent_app_number] => 15/028788 [patent_app_country] => US [patent_app_date] => 2014-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24409 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15028788 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/028788
ZWITTERIONIC POLYSACCHARIDE POLYMERS HAVING ANTIFOULING, ANTIMICROBIAL AND OPTICAL TRANSPARENCY PROPERTIES Oct 13, 2014 Abandoned
Menu